WHO trial guidance goes beyond race and gender when tackling diversity
The WHO’s guidance provides direction on diversity and how to include patients who are pregnant, lactating and from low-middle income countries.
Regulation
‘Major milestone’ for UK clinical trials as new framework laid in parliament
US Border Protection warns pharma of risks with incorrect biologic importation
DR.NOAH BIOTECH’s Phase I trial of ALS treatment receives approval from FDA
FDA grants IND clearance for Find’s Phase I chronic optic neuropathy trial
Ascentage Pharma receives approval for myelodysplastic syndrome treatment trial
India’s CDSCO waives local trials for foreign-approved drugs
China’s NMPA grants clearance for Biosyngen’s nasopharyngeal carcinoma trial
